GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Inventory-to-Revenue

Nuvation Bio (Nuvation Bio) Inventory-to-Revenue : 0.00 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nuvation Bio's Average Total Inventories for the quarter that ended in Sep. 2021 was $0.00 Mil. Nuvation Bio's Revenue for the three months ended in Sep. 2021 was $0.00 Mil.

Nuvation Bio's Inventory-to-Revenue for the quarter that ended in Sep. 2021 stayed the same from Jun. 2021 (0.00) to Jun. 2021 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Nuvation Bio Inventory-to-Revenue Historical Data

The historical data trend for Nuvation Bio's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Inventory-to-Revenue Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Inventory-to-Revenue
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Inventory-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's Inventory-to-Revenue

For the Biotechnology subindustry, Nuvation Bio's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Inventory-to-Revenue falls into.



Nuvation Bio Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nuvation Bio's Inventory-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Inventory-to-Revenue (A: Dec. 2020 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: Dec. 2020 )) / count ) / Revenue (A: Dec. 2020 )
=( ( + 0) / 1 ) / 0
=0 / 0
=N/A

Nuvation Bio's Inventory-to-Revenue for the quarter that ended in Sep. 2021 is calculated as

Inventory-to-Revenue (Q: Sep. 2021 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2021 ) + Total Inventories (Q: Sep. 2021 )) / count ) / Revenue (Q: Sep. 2021 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nuvation Bio's Days Inventory for the three months ended in Sep. 2021 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2021 )/Cost of Goods Sold (Q: Sep. 2021 )*Days in Period
=0/0*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nuvation Bio's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2021 ) / Average Total Inventories (Q: Sep. 2021 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.